TET MEDICAL

Medtech · Private

Point-of-care diagnostic device using tethered enzyme technology to measure liver enzymes (AST/ALT) from blood samples

Grants
$506K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Tethered Enzyme Technology for PoC and At-home Real-time Monitoring of Liver Function$324,962
Federal grantDepartment of Agriculture · Highly Pathogenic Avian Influenza (hpai), Already A Major Problem For Poultry Farms, Has Recently Caused Outbreaks In Dairy Cattle Herds Around The Country, Drastically Reducing The Viable Milk Output Of Affected Cows. Furthermore, Evidence Shows That The Virus Can Be Transmitted To Humans Through Contact With Infected Animals, Raising Concerns Of Increased Spread And Possible Recombination With A Human Strain Of Influenza. The Usda Has Implemented Mandatory Testing For Animals Before Crossing S$181,392
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2015Cohesys Inc.——
2016CellDrop Inc——
2017NEUROSESSMENTS LLC——
2018TET MEDICAL ——
2019NEURALENZ, INC——
2020PRECYTE INC——
2021O-RAY PHARMA——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.